These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 9854164
1. Sweet's syndrome associated with granulocyte colony-stimulating factor. Hasegawa M, Sato S, Nakada M, Nitta H, Shirasaki H, Kasahara K, Takehara K. Eur J Dermatol; 1998; 8(7):503-5. PubMed ID: 9854164 [Abstract] [Full Text] [Related]
2. [Sweet syndrome following therapeutic use of granulocyte colony stimulating factor]. Veres K, Haraszti A, Nemes Z, Zeher M. Orv Hetil; 1999 May 09; 140(19):1059-61. PubMed ID: 10339998 [Abstract] [Full Text] [Related]
3. Sweet's syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor. Thompson MA, Dyson SW, Faderl S. Am J Hematol; 2006 Sep 09; 81(9):703-5. PubMed ID: 16838322 [Abstract] [Full Text] [Related]
4. [Sweet's syndrome in patient with refractory anemia during recombinant human granulocyte colony stimulating factor therapy]. Sai M, Kawanishi Y, Itoh Y, Aizawa S, Kawashima T, Koga M, Kuratsuji T, Toyama K. Rinsho Ketsueki; 1990 Feb 09; 31(2):245-8. PubMed ID: 1691795 [Abstract] [Full Text] [Related]
5. [Sweet's syndrome in a patient with chronic myeloproliferative disorder during recombinant human granulocyte colony stimulating factor therapy]. Shiga Y, Shichishima T, Kamei K, Watanabe K, Ishibashi T, Maruyama Y. Rinsho Ketsueki; 1995 Apr 09; 36(4):353-8. PubMed ID: 7540225 [Abstract] [Full Text] [Related]
6. Sweet's syndrome with subcutaneous involvement associated with pegfilgrastim treatment: first reported case. Llamas-Velasco M, García-Martín P, Sánchez-Pérez J, Fraga J, García-Diez A. J Cutan Pathol; 2013 Jan 09; 40(1):46-9. PubMed ID: 23131080 [Abstract] [Full Text] [Related]
7. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study. Timmer-Bonte JN, de Boo TM, Smit HJ, Biesma B, Wilschut FA, Cheragwandi SA, Termeer A, Hensing CA, Akkermans J, Adang EM, Bootsma GP, Tjan-Heijnen VC. J Clin Oncol; 2005 Nov 01; 23(31):7974-84. PubMed ID: 16258098 [Abstract] [Full Text] [Related]
8. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients. Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P. Haematologica; 1999 Nov 01; 84(11):1016-23. PubMed ID: 10553163 [Abstract] [Full Text] [Related]
9. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ. Biol Blood Marrow Transplant; 2004 Jun 01; 10(6):395-404. PubMed ID: 15148493 [Abstract] [Full Text] [Related]
11. [Two cases of malignant lymphoma with high fever and C-reactive protein (CRP) elevation after treatment with granulocyte colony-stimulating factor (G-CSF)]. Kanbayashi Y, Mukoyama N, Nishida K, Shimizu D, Matsumoto Y, Nomura K, Horiike S, Taniwaki M. Gan To Kagaku Ryoho; 2006 Jan 01; 33(1):73-7. PubMed ID: 16410701 [Abstract] [Full Text] [Related]
12. Sweet syndrome associated with G-CSF treatment in a child with glycogen storage disease type Ib. Garty BZ, Levy I, Nitzan M, Barak Y. Pediatrics; 1996 Mar 01; 97(3):401-3. PubMed ID: 8604280 [Abstract] [Full Text] [Related]
13. Cutaneous manifestations of granulocyte colony-stimulating factor. White JM, Mufti GJ, Salisbury JR, du Vivier AW. Clin Exp Dermatol; 2006 Mar 01; 31(2):206-7. PubMed ID: 16487091 [Abstract] [Full Text] [Related]
14. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR. J Natl Cancer Inst; 2007 Feb 07; 99(3):196-205. PubMed ID: 17284714 [Abstract] [Full Text] [Related]
15. Sweet's syndrome associated with G-CSF. Paydaş S, Sahin B, Seyrek E, Soylu M, Gonlusen G, Acar A, Tuncer I. Br J Haematol; 1993 Sep 07; 85(1):191-2. PubMed ID: 7504506 [Abstract] [Full Text] [Related]
16. Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy. Huisman C, Biesma B, Postmus PE, Giaccone G, Schramel FM, Smit EF. Br J Cancer; 2001 Nov 16; 85(10):1456-61. PubMed ID: 11720428 [Abstract] [Full Text] [Related]
17. [Bortezomib-induced eruption: Sweet syndrome? Two case reports]. Thuillier D, Lenglet A, Chaby G, Royer R, Vaida I, Viseux V, Dadban A, Billet A, Christophe O, Chatelain D, Marolleau JP, Lok C, Damaj G. Ann Dermatol Venereol; 2009 May 16; 136(5):427-30. PubMed ID: 19442799 [Abstract] [Full Text] [Related]
19. Bullous Sweet's syndrome in congenital neutropenia: association with pegfilgrastim. Draper BK, Robbins JB, Stricklin GP. J Am Acad Dermatol; 2005 May 16; 52(5):901-5. PubMed ID: 15858487 [Abstract] [Full Text] [Related]
20. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy. Pentheroudakis G, Malamou-Mitsi V, Briasoulis E, Damala K, Vassou A, Vartholomatos G, Kolaitis N, Pavlidis N. Cancer; 2004 Oct 15; 101(8):1767-75. PubMed ID: 15386335 [Abstract] [Full Text] [Related] Page: [Next] [New Search]